Sorry, HRTX is the snake oil vendor, not HZNP.
Good luck with FOLD anyway. It probably will get approval, but not the revenues.
Sorry, but hznp and fold are snake oil companies.
Well, maybe fold has a hype up market share for its Gaucher drug
Because many trial investigators have been debarred for dishonesty, and there are many more who have not been caught.
That Sarepta drug will be like Dendreon's. Expensive, yet questionable efficacy.
Yeah. It's a question of what will happen first. The rate hike, or ph3 results. I wish the Fed will state that there will be a rate hike in September, but we reserve the right to change our minds.
...until phase 3 results are out. Save money for when the fed announces the interest rate hike, then buy on the dump. That is what most everybody is doing - waiting.
Careful with your short, Mac. I think the hedgies are going to push this above $9, that is, a little above their load price, before they stop, and take profit.
cchrag, 853 is not considered standard chemo. ADCs are not considered chemo, and are supposed to be much safer than chemo, and ADCs give much better QOL to patients than chemo. No hair loss, less nausea, less probability of developing new cancers due to the DC, etc.